Research ArticleCardiovascular
Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury
Arpad Lux, Peter Pokreisz, Melissa Swinnen, Ellen Caluwe, Hilde Gillijns, Zsolt Szelid, Bela Merkely and Stefan P. Janssens
Journal of Pharmacology and Experimental Therapeutics February 2016, 356 (2) 284-292; DOI: https://doi.org/10.1124/jpet.115.227850
Arpad Lux
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Peter Pokreisz
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Melissa Swinnen
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Ellen Caluwe
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Hilde Gillijns
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Zsolt Szelid
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Bela Merkely
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Stefan P. Janssens
Heart and Vascular Center, Semmelweis University, Budapest, Hungary (A.L., Zs.Sz., B.M.); Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.P., M.S., E.C., H.G., S.P.J.); Division of Cardiology, University Hospitals KU Leuven, Leuven, Belgium (S.P.J.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
Myocardial Protection by Combined iNO and PDE5 Inhibition
Arpad Lux, Peter Pokreisz, Melissa Swinnen, Ellen Caluwe, Hilde Gillijns, Zsolt Szelid, Bela Merkely and Stefan P. Janssens
Journal of Pharmacology and Experimental Therapeutics February 1, 2016, 356 (2) 284-292; DOI: https://doi.org/10.1124/jpet.115.227850
Research ArticleCardiovascular
Myocardial Protection by Combined iNO and PDE5 Inhibition
Arpad Lux, Peter Pokreisz, Melissa Swinnen, Ellen Caluwe, Hilde Gillijns, Zsolt Szelid, Bela Merkely and Stefan P. Janssens
Journal of Pharmacology and Experimental Therapeutics February 1, 2016, 356 (2) 284-292; DOI: https://doi.org/10.1124/jpet.115.227850
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement